Insulin-like-growth-factor-binding-protein-3 (IGFBP-3) contrasts melanoma progression in vitro and in vivo.
Naspi A, Panasiti V, Abbate F, Roberti V, Devirgiliis V, Curzio M, Borghi M, Lozupone F, Carotti S, Morini S, Gaudio E, Calvieri S, Londei P.
Naspi A, et al. Among authors: calvieri s.
PLoS One. 2014 Jun 6;9(6):e98641. doi: 10.1371/journal.pone.0098641. eCollection 2014.
PLoS One. 2014.
PMID: 24905466
Free PMC article.